Pharmafile Logo
Pharmafocus logo
Advanced Search

Press release

Showing 15 posts of 534 posts found.

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

April 4, 2023
Business Services

Cambridge, UK, 04 April 2023 – Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company dedicated to resolving …

News
Press release

Landmark data published on successful NTCD-M3 gut colonisation after fidaxomicin administration

April 4, 2023
Business Services

Brighton, United Kingdom – 4 April 2023 – Destiny Pharma (AIM: DEST), a clinical stage innovative biotechnology company focused on …

News
Press release

PHARMANOVIA RECEIVES SBTi APPROVAL FOR NET ZERO EMISSION TARGETS

April 4, 2023
Business Services

Basildon, UK, 3 April 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already established …

News
Press release

Orbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticals

April 4, 2023
Business Services

New Jersey, USA, and Oxford, UK, 3rd April 2023: Evergreen Discovery (Evergreen), a leading radiopharmaceutical drug development company with a …

News
Press release

CrestOptics launches CICERO system to provide all-in-one solution for widefield and spinning disk confocal microscopy

April 3, 2023
Business Services

Rome, IT, 03 April, 2023: CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and …

News
Press release

Sequana Medical announces submission of Investigational New Drug (IND) application for DSR® 2.0 for treatment of congestive heart failure

April 3, 2023
Business Services

Ghent, Belgium – 03 April 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana

News
Press release

Novo Nordisk Foundation to support crucial education of health professionals in India and East Africa with up to DKK 1bn (USD 140m)

April 3, 2023
Business Services

Lack of access to qualified health personnel combined with an alarming prevalence of noncommunicable diseases (NCDs) such as cardiometabolic diseases …

News
Press release

Redx Confirms Proposed Business Combination with Jounce has Formally Lapsed

April 3, 2023
Business Services

Alderley Park, UK, 3 April 2023 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, …

News
Press release

Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) publish Ph3 data evaluating lebrikizumab efficacy and safety in moderate-to-severe atopic dermatitis

March 31, 2023
Business Services Almirall, Dermatology, dermatology, lebrikizumab

BARCELONA, Spain. March 31, 2023 – Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, announced today the …

News
Press release

HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer

March 31, 2023
Business Services

Hong Kong, Shanghai & Florham Park, NJ — Friday, March 31, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM, HKEX:​13) today announces that …

News
Press release

Expansion of Scientific Affairs Group

March 30, 2023
Business Services

Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …

News
Press release

Granular Therapeutics to accelerate development of next-generation pipeline for treating mast cell driven diseases

March 30, 2023
Business Services

London, UK, March 30, 2023 – Granular Therapeutics, (Granular) a private biotech company specialising in precision biologic therapies for treating …

News
Press release

Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics

March 30, 2023
Business Services

Netanya, Israel, March 30, 2023 – Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced …

News
Press release

PHARMANOVIA EXPANDS EXCLUSIVE LICENSING COLLABORATION WITH AQUESTIVE THERAPEUTICS FOR DIAZEPAM BUCCAL FILM

March 30, 2023
Business Services

Basildon, UK – For immediate release, 27 March 2023   Pharmanovia, a global pharmaceutical company that revitalises, extends and expands …

News
Press release

Unite Health: Thousands Honor Pandemic ‘Influencers’ Through COVID-19 Social Media Awards

March 30, 2023
Business Services

  London, UK | In a global display of appreciation, thousands of people are recognizing social media influencers who used …

News
Press release

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024